Influência da dexmedetomidina na concentração expirada do sevoflurano: avaliação pelo índice bispectral, taxa de supressão e análise espectral da potência do eletroencefalograma
Influence of dexmedetomidine upon sevoflurane end-expiratory concentration: evaluation by bispectral index, suppression rate and electroencephalographic power spectral analysis
Rogean Rodrigues Nunes; Sara Lúcia Cavalcante
Resumo
Palavras-chave
Abstract
Keywords
References
Aantaa R, Jaakola ML, Kallio A. Reduction of the minimum alveolar concentration of isoflurane by dexmedetomidine. Anesthesiology. 1997;86:1055-1060.
Aantaa R, Scheinin M. Ahpha2-Adrenergic agents in anaesthesia. Acta Anaesthesiol Scand. 1993;37:433-448.
Prys-Roberts C. Anaesthesia: a practical or impractical construct?. Br J Anaesth. 1987;59:1341-1345.
Rampil IJ. A primer for EEG signal processing in anesthesia. Anesthesiology. 1998;89:980-1002.
Schwender D, Daunderer M, Klasing S. Power spectral analysis of the electroencephalogram during increasing end-expiratory concentrations of isoflurane, desflurane and sevoflurane. Anaesthesia. 1998;53:335-342.
Schwender D, Daunderer M, Mulzer S. Spectral edge frequency of the electroencephalogram to monitor "depth" of anaesthesia with isoflurane or propofol. Br J Anaesth. 1996;77:179-184.
Bloor BC, Ward DS, Belleville JP. Effects of intravenous dexmedetomidine in humans, II: hemodynamic changes. Anesthesiology. 1992;77:1134-1142.
Kallio A, Scheinin M, Koulu M. Effects of dexmedetomidine, a selective alpha 2-adrenoceptor agonist, on hemodynamic control mechanisms. Clin Pharmacol Ther. 1989;46:33-42.
Viby-Mogensen J, Engbaek J, Eriksson Ll. Good clinical research practice (GCRP) in pharmacodinamyc studies of neuromuscular blocking agents. Acta Anaesthesiol Scand. 1996;40:59-74.
Alkis N, Keçik Y. Oral Metal: Monitoring of cerebral oxygenation by spectroscopy and jugular bulb venous O2 saturation during carotid endarterectomy. Br J Anaesth. 1997;78(A.52):15.
Hungria H. Otorrinolaringologia. 1995:297-306.
Billard V, Gambus PL, Chamoun N. A comparison of spectral edge, delta power, and bispectral index as EEG measures of alfentanil, propofol, and midazolam drug effect. Clin Pharmacol Ther. 1997;61:45-58.
Bhana N, Goa KL, McClenllan KJ. Dexmedetomidine. Drugs. 2000;59:263-268.
Hall JE, Uhrich TD, Barney JA. Sedative, amnestic, and analgesic properties of small-dose dexmedetomidine infusions. Anesth Analg. 2000;93:699-705.
Guo TZ, Jiang JY, Buttermann AE. Dexmedetomidine injection into the locus ceruleus produces antinociception. Anesthesiology. 1997;84:873-881.
De Kock M, Crochet B, Morimont C. Intravenous or epidural clonidine for intra-and postoperative analgesia. Anesthesiology. 1993;79:525-531.
Schmeling WT, Ganjoo P, Staunton M. Pretreatment with dexmedetomidine: altered indices of anesthetic depth for halothane in the neuraxis of cats. Anesth Analg. 1999;88:625-632.
Correa SC, Nacif CC, Reid K. Inhibition of adenylate cyclase in the locus ceruleus mediates the hypnotic response to alpha-2-agonist in the rat. J Pharmacol Exp Ther. 1992;236:1046-1049.
Nacif CC, Correa SC, Chang LL. Perturbation of ion conductance in the locus ceruleus alters the hypnotic response to the alpha-2-adrenergic agonist dexmedetomidine in the locus ceruleus in rats. Anesthesiology. 1994;81:1527-1534.
Kamibayashi T, Maze M. Clinical uses of alpha-2-adrenergic agonists. Anesthesiology. 2000;93:1345-1349.
Lakhlani PP, MacMillan LB, Guo TZ. Substitution of a mutant alpha2A-adrenergic receptor via "hit and run" gene targeting reveals the role of this subtype in sedative, analgesic, and anesthetic-sparing responses in vivo. Proc Natl Acad Sci USA. 1997;94:9950-9955.
McCallum JB, Boban N, Hogan Q. The mechanism of alpha-2-adrenergic inhibition of sympathetic ganglionic transmission. Anesth Analg. 1998;87:503-510.
Scholz J, Tonner PH. [alpha ] -2-adrenoceptor agonists in anaesthesia: a new paradigm. Curr Opin Anaesthesiol. 2000;13:437-442.
Link RE, Dessai K, Hein L. Cardiovascular regulation in mice lacking alpha-2-adrenergic receptor subtypes b and c. Science. 1996;273:803-305.
Ebert TJ, Hall JE, Barney JA. The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology. 2000;93:382-394.
Khan ZP, Ferguson CN, Jones RM. Alpha-2 - and imidazoline receptor agonists: their pharmacology and therapeutic role. Anaesthesia. 1999;54:146-165.
Benhamou D, Veillette Y, Narchi P. Ventilatory affects of premedication with clonidine. Anesth Analg. 1991;73:799-803.
Ooi R, Pattison J, Feldman AS. The effects of intravenous clonidine on ventilation. Anaesthesia. 1991;46:632-633.
Penon C, Ecoffey C, Cohen SE. Ventilatory response to carbon dioxide after epidural clonidine injection. Anesth Analg. 1991;72:761-764.
Zornow MH. Ventilatory, hemodynamic and sedative effects of the alpha 2 adrenergic agonist, dexmedetomidine. Neuropharmacology. 1991;30:1065-1071.
Belleville JP, Ward DS, Bloor BC. Effects of intravenous dexmedetomidine in humans. Anesthesiology. 1992;77:1125-1133.
Aantaa R, Kanto J, Scheinin M. Dexmedetomidine, an alpha-2-adrenoceptor agonist, reduces anesthetic requirements for patients undergoing gynecologic surgery. Anesthesiology. 1990;73:230-235.
Scheinin H, Jaakola ML, Sjovall S. Intramuscular dexmedetomidine as premedication for general anesthesia. Anesthesiology. 1993;78:1065-1075.
Erkola O, Korttila K, Aho M. A comparison of IM dexmedetomidine and midazolam premedication for elective abdominal hysterectomy. Anesth Analg. 1994;79:646-653.
Aho MS, Erkola O, Scheinin H. Effects of intravenously administered dexmedetomidine on pain after laparoscopic tubal ligation. Anesth Analg. 1991;73:112-118.
Ossipov MH, Harris S, Lloyd P. Antinociceptive interaction between opioids and dexmedetomidine: systemic addtivity and spinal synergy. Anesthesiology. 1990;73:1227-1235.
Aho M, Erkola O, Kallio A. Dexmedetomidine infusion for maintenance of anesthesia in patients undergoing abdominal hysterectomy. Anesth Analg. 1992;75:940-946.
Roizen MF, White PF, Eger EI. Effects of ablation of serotonin or norepinephine brain stem areas on halothane and cyclopropane MACs in rats. Anesthesiology. 1978;78:252-255.
Segal IS, Vickery RG, Walton JK. Dexmedetomidine diminishes halothane anesthetic requirements in rats through a postsynaptic alpha-2-adrenergic receptor. Anesthesiology. 1988;69:818-823.
Buhrer M, Mappes A, Lauber R. Dexmedetomidine decreases thiopental dose requirement and alters distribution pharmacokinetics. Anesthesiology. 1994;80:1216-1227.
Bachand R, Scholz J, Pinaud M. The effects of dexmedetomidine in patients in the intensive care setting. Intensive Care Med. 1999;25(^s1):S160.
Mantz J, Goldfarb G, Lehot J-J. Dexmedetomidine efficacy for ICU postoperative sedation. Anesthesiology. 1999;91:A197.
Fragen RJ, Fitzgerald PC. Effect of dexmedetomidine on the minimum alveolar concentration (MAC) of sevoflurane in adults age 55 to 70 years. J Clin Anesth. 1999;11:466-470.
Brown DV, Avramov MN, Tuman KJ. The effect of dexmedetomidine on EEG-bispectral index. Anesth Analg. 1999;88:52S.